Current Clinical Trials for Lung

CALGB 140503 - A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (d 2 CM) Peripheral Non-Small Cell Lung Cancer

CALGB 30607 - Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer

CALGB 30610 - Phase III Comparison of Thoracic Radiotherapy Regimens In Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide

CALGB 30801 - A Randomized Phase III Double-blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced NSCLC

GCC 0757 - (ECOG 1505) A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (4 cm or larger) - IIIA Non-Small Cell Lung Cancer (NSCLC)

GCC 1046 - Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations

GCC 1057 - Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients With Varying Degrees of Hepatic Impairment

GCC1201 - A randomized, double-blind, multicenter, Phase III study of everolimus (RAD001) plus best supportive care versus placebo plus best supportive care in the treatment of patients with advanced NET of GI or lung origin - RADIANT 4

RTOG 0617/H-29555 - A Randomized Phase III Comparison of Standard-Dose (60 GY) Versus High-Dose (74 GY) Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) in Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer [NCCTG (N0628), CALGB (30609)]

RTOG 0813 - SEAMLESS PHASE I/II STUDY OF STEREOTACTIC LUNG RADIOTHERAPY (SBRT) FOR EARLY STAGE, CENTRALLY LOCATED, NON-SMALL CELL LUNG CANCER (NSCLC) IN MEDICALLY INOPERABLE PATIENTS

RTOG 0839 - Phase II Study of Pre-Op Chemoradiotherapy +/- Panitumumab in Advanced NSCLC

RTOG 0915 - A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules For Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer



Email this Page                                                                     Print this Page

Home Site Map Disclaimer University of Maryland Greenebaum Cancer Center UM School of Medicine UM Medical System UM Medical Center Text: If you would like to make an appointment or talk to someone about our services please call 1-800-888-8823. Physicians can call our dedicated consultation referral service at 1-800-373-4111.